New frontiers in circulating tumour cell analysis : a reference guide for bimolecular profiling towards translational clinical use

Therese M. Becker, Nicole J. Caixeiro, Stephanie H. Lim, Annette Tognela, Norbert Kienzle, Kieran F. Scott, Kevin J. Spring, Paul de Souza

    Research output: Contribution to journalArticlepeer-review

    30 Citations (Scopus)

    Abstract

    Circulating tumor cells (CTCs) are now routinely isolated from blood, and measurement of CTC concentrations appears to correlate well with survival in patients with cancer. Interrogation of the molecular profile of CTCs for expression of protein biomarkers, genetic variants and gene expression provides opportunities to use this information to guide personalized treatment, monitor therapy and detect emerging resistance. However, successful application of profiling techniques requires analyses that deliver a reliable and clinically relevant representation of a patient's cancer as it changes with time. Here, we comprehensively review the current knowledge of therapeutically relevant biomarkers in isolated CTCs obtained by fluorescence imaging and genomic profiling approaches. The reviewed data support the notion that molecular profiling of CTCs will provide a reliable representation or surrogate index of tumor burden. Large-scale translational trials, many currently in progress, will provide critical data to progress CTC analysis toward wider clinical use in personalized treatment.
    Original languageEnglish
    Pages (from-to)2523-2533
    Number of pages11
    JournalInternational Journal of Cancer
    Volume134
    Issue number11
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'New frontiers in circulating tumour cell analysis : a reference guide for bimolecular profiling towards translational clinical use'. Together they form a unique fingerprint.

    Cite this